再生医療の世界市場：細胞治療、遺伝子治療、免疫治療、組織工学...市場調査レポートについてご紹介

1 Introduction (Page No. – 14)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency & Pricing
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 18)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Market Share Estimation
2.3.1 Key Data From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.3 Assumptions for the Study

3 Executive Summary (Page No. – 25)

4 Premium Insights (Page No. – 28)
4.1 Lucrative Opportunities in the Regenerative Medicines Market

5 Market Overview (Page No. – 31)
5.1 Introduction
5.2 Market Segmentation
5.2.1 Market Segmentation, By Therapy
5.2.2 Market Segmentation, By Product
5.2.3 Market Segmentation, By Application
5.3 Market Dynamics
5.4 Drivers
5.4.1 Government and Private Funding to Support the Development of Regenerative Medicines Products
5.4.2 Increase in Global Healthcare Expenditure
5.4.3 Increase in Aging Population
5.5 Restraints
5.5.1 Stringent Regulatory Approval Process for Regenerative Medicines
5.5.2 Ethical Issues With the Use of Embryonic Stem Cell for Research and Development
5.6 Opportunities
5.6.1 Rising Demand for Organ Transplantation
5.6.2 Strong Product Pipeline to Drive the Market
5.6.3 Increase in R&D Spending
5.7 Challenges
5.7.1 Lack of Clear Regulatory Guidelines
5.7.2 High Costs Incurred in Stem Cell Processing

6 Global Regenerative Medicines Market, By Product (Page No. – 40)
6.1 Introduction
6.2 Cell-Based Products
6.2.1 Autologous Cell-Based Products
6.2.2 Allogeneic Cell-Based Products
6.3 Acellular Products

7 Global Regenerative Medicines Market, By Therapy (Page No. – 50)
7.1 Introduction
7.2 Cell Therapy
7.3 Gene Therapy
7.4 Tissue Engineering
7.5 Immunotherapy

8 Regenerative Medicines Market, By Application (Page No. – 58)
8.1 Introduction
8.2 Orthopedic & Musculoskeletal Spine
8.3 Dermatology
8.4 Cardiovascular
8.5 Central Nervous System
8.6 Oncology
8.7 Diabetes
8.8 Others

9 Global Regenerative Medicines Market, By Region (Page No. – 71)
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest of Europe (RoE)
9.4 Asia-Pacific
9.5 Rest of the World (RoW)

10 Competitive Landscape (Page No. – 126)
10.1 Overview
10.2 Market Share Analysis
10.3 Competitive Situation and Trends
10.3.1 New Product Launches
10.3.2 Acquisitions
10.3.3 Regulatory Approvals
10.3.4 Partnerships

11 Company Profile (Page No. – 133)
(Overview, Financial*, Products & Services, Strategy, and Developments)
11.1 Introduction
11.2 Vertex Pharmaceuticals Incorporated
11.3 Celgene Corporation
11.4 Acelity (KCI Licensing)
11.5 Nuvasive, Inc.
11.6 Organogenesis Inc.
11.7 Japan Tissue Engineering Co., Ltd (Subsidiary of Fujifilm Holdings Corporation)
11.8 Vericel Corporation
11.9 Cytori Therapeutics Inc.
11.10 Stemcells, Inc.
11.11 Advantagene, Inc.
11.12 Mesoblast Ltd

*Details Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. – 153)
12.1 Insights From Industry Experts
12.2 Discussion Guide
12.3 Introducing RT: Real-Time Market Intelligence
12.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.5 Available Customizations
12.6 Related Reports